SCHEMBL25926510

SCHEMBL25926510

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4c(c3)oc3ccc(-c5ccc6c(c5)oc5cc(-n7c8ccccc8c8ccccc87)ccc56)cc34)n2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
ATM Q13315 1/20 0.36
PTGER4 P35408 1/20 0.36
CHEK2 O96017 1/20 0.36
PLA2G2A P14555 3/20 0.35
PLA2G4A P47712 3/20 0.35
MMP12 P39900 2/20 0.34
HCRTR1 O43613 1/20 0.34
MMP13 P45452 1/20 0.33
PLA2G10 O15496 1/20 0.33
ALDH1A1 P00352 4/20 0.33
HPGD P15428 4/20 0.33
MEN1 O00255 3/20 0.33
MAPT P10636 3/20 0.33
KMT2A Q03164 3/20 0.33
AHR P35869 2/20 0.33
PGR P06401 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25926645 1.00 KDM4E (0.36) KDM4EL3MBTL1ATMPTGER4CHEK2
SCHEMBL25926620 1.00 KDM4E (0.36) KDM4EL3MBTL1ATMPTGER4CHEK2
SCHEMBL25926609 1.00 KDM4E (0.36) KDM4EL3MBTL1ATMPTGER4CHEK2
SCHEMBL25926482 1.00 KDM4E (0.36) KDM4EL3MBTL1ATMPTGER4CHEK2
SCHEMBL25926523 1.00 KDM4E (0.36) KDM4EL3MBTL1ATMPTGER4CHEK2
SCHEMBL25926655 0.99 KDM4E (0.37) KDM4EL3MBTL1ATMPTGER4CHEK2
SCHEMBL24232056 0.98 KDM4E (0.36) KDM4EL3MBTL1ATMPTGER4CHEK2
SCHEMBL25926611 0.98 KDM4E (0.36) KDM4EL3MBTL1ATMPTGER4CHEK2
SCHEMBL25926529 0.98 KDM4E (0.36) KDM4EL3MBTL1ATMPTGER4CHEK2
SCHEMBL25929849 0.98 KDM4E (0.36) KDM4EL3MBTL1ATMPTGER4CHEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230247902-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE CRY1, PPOX, ORC3 KDM4E 2352/4885L3MBTL1 1454/4885ATM 2148/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.